MétaCan
Menu
← Back to cohort
Record W1982407132 · doi:10.1177/1715163514522762

The elderly and the future of pharmacy / Les personnes âgées et l’avenir de la pharmacie

2014· article· fr· W1982407132 on OpenAlexvenueaboutno aff
Ross T. Tsuyuki

Bibliographic record

VenueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada · 2014
Typearticle
Languagefr
FieldMedicine
TopicPharmaceutical Practices and Patient Outcomes
Canadian institutionsnot available
Fundersnot available
KeywordsPharmacyHumanitiesMedicineGerontologyPhilosophyFamily medicine

Abstract

fetched live from OpenAlex

The elderly are our future. Think about it. We need to establish ourselves as providers of patient-centred care. But where do you start? One approach would be to target those at highest risk of poor outcomes—the so-called low-hanging fruit. Those at highest risk of poor outcomes also stand to benefit the most from interventions. The elderly fit these specifications nicely. Canadians older than 65 years already constitute 15% of our population, and that is expected to increase to almost one-third in the next 25 years.1 As you know, the elderly are particularly vulnerable to polypharmacy and a myriad of drug-related problems such as falls, confusion and hospitalizations.2 If you need to prioritize your care, it makes sense to focus on the elderly. In this issue of the journal, Dr. Cara Tannenbaum of the Universite de Montreal reports on the educational needs of pharmacists to improve geriatric care. Dr. Tannenbaum is a geriatrician with a unique perspective—she is the Michel Saucier Endowed Chair in Geriatric Pharmacology, Health, and Aging with the Faculte de pharmacie and, as such, has been very involved in teaching undergraduate pharmacy students. She is involved in establishing a new program to partner pharmacy students with medical students and residents to ensure interprofessional management of polypharmacy in older patients. She believes that “the pharmacist’s role in patient management is critical to complement that of other health care professionals.” But it appears we have some homework to do. In her survey of over 700 pharmacists in Quebec, Dr. Tannenbaum found that less than half were aware of the high prevalence of polypharmacy, inappropriate prescribing and drug-related hospitalizations and falls in the elderly. Only 41% of community pharmacists knew of the Beers criteria for inappropriate drugs in the elderly. Related to this, less than 6% of pharmacists knew that short-acting benzodiazepines should not be prescribed to the elderly. Most pharmacists recognized the need for more education around drug-related issues in the care of older patients. Also in this issue is another in the case series prepared as a collaboration of the Geriatric Day Hospital of Bruyere Continuing Care, the CMAJ, Canadian Family Physician and CPJ. In this article, Dr. Barb Farrell and colleagues highlight the issues surrounding drug-induced hypoglycemia and hypotension and falls in the elderly. They call for a balance between what is recommended in practice guidelines and the significant risk of harm caused by evidence-based medications in the frail elderly. Indeed, we can all learn from these informative cases. As Dr. Tannenbaum points out, as the scope of pharmacy practice expands, physicians (and patients) will become more dependent on pharmacists to optimize medication management for the elderly.2 To this end, over the next few issues, you will see a number of papers addressing pharmacist care of the elderly. Older Canadians need us (and we need them). Les personnes âgees sont notre avenir. En effet, nous savons que nous devons nous imposer comme des prestataires de soins axes sur le patient, mais par ou commencer? L’une des strategies pourrait consister a viser les personnes qui presentent le plus de risques de problemes de sante : les premieres cibles logiques, en quelque sorte. Les personnes qui sont le plus a risque sont egalement celles qui profiteraient le plus de nos interventions. Les personnes âgees correspondent tres bien a ces caracteristiques. Les Canadiens de plus de 65 ans representent deja 15 % de notre population, et ce chiffre devrait atteindre pres de 33 % dans les 25 prochaines annees1. Comme vous le savez, les personnes âgees sont particulierement vulnerables a la polypharmacie, ainsi qu’a la multitude de problemes qui l’accompagnent, tels que les chutes, la confusion et l’hospitalisation2. Si nous devons hierarchiser nos soins, il est logique de commencer par les aines. Dans ce numero, Dre Cara Tannenbaum de l’Universite de Montreal nous parlera des besoins en matiere de formation des pharmaciens afin d’ameliorer les soins geriatriques. Dre Tannenbaum est non seulement geriatre, mais egalement titulaire de la Chaire pharmaceutique Michel Saucier en sante et vieillissement de la Faculte de pharmacie. A ce titre, elle joue un grand role dans l’enseignement des etudiants de premier cycle en pharmacie. Elle participe a l’elaboration d’un nouveau programme destine a etablir des partenariats entre les etudiants en pharmacie et les etudiants en medecine et les residents en vue d’une gestion interprofessionnelle de la polypharmacie chez les personnes âgees. Selon elle, « le pharmacien joue un role essentiel dans la prise en charge des patients en complement des autres professionnels de la sante. » Il semble toutefois que nous ayons du travail a faire pour y parvenir. Dans son enquete menee aupres de plus de 700 pharmaciens au Quebec, Dre Tannenbaum a constate que moins de la moitie d’entre eux etaient au courant de la forte prevalence de la polypharmacie, des hospitalisations dues a des medicaments ou aux ordonnances inadequates, ainsi que des chutes chez les personnes âgees. Seuls 41 % des pharmaciens communautaires connaissaient les criteres de Beers enoncant les medicaments que l’on devrait eviter de donner aux personnes âgees. De plus, moins de 6 % des pharmaciens savaient que les benzodiazepines a action breve ne devraient jamais etre prescrites a des personnes âgees. La plupart des pharmaciens ont reconnu qu’il faudrait davantage d’education sur les problemes lies aux medicaments dans la prestation de soins aux patients âges. Dans ce numero, vous trouverez egalement une nouvelle serie de cas preparee par l’hopital geriatrique de jour ‒ Soins continus de Bruyere en collaboration avec le Journal de l’Association medicale canadienne, Le medecin de famille canadien et la Revue des pharmaciens du Canada. Dans cet article, Dre Barb Farrell et ses confreres soulignent les problemes lies a l’hypoglycemie et a l’hypotension medicamenteuses et aux chutes chez les personnes âgees. Ils appellent a trouver l’equilibre entre les recommandations des lignes directrices de pratique et les risques importants que presentent les medicaments fondes sur des preuves chez les personnes âgees fragiles. Ces etudes de cas nous seront sans doute utiles a tous. Comme l’indique Dre Tannenbaum, a mesure que la pratique de la pharmacie elargit sa portee, les medecins (et les patients) dependront de plus en plus des pharmaciens pour optimiser la gestion des medicaments chez les personnes âgees2. A cette fin, vous trouverez dans les prochains numeros une serie d’articles portant sur les soins des personnes âgees offerts par le pharmacien. Les aines canadiens ont besoin de nous, et nous d’eux.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.022
Threshold uncertainty score0.045

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0060.007
Scholarly communication0.0110.013
Open science0.0010.004
Research integrity0.0080.011
Insufficient payload (model declined to judge)0.0110.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.343
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2014
Admission routes2
Has abstractyes

Explore more

Same venueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada→Same topicPharmaceutical Practices and Patient Outcomes→French-language works237,207→